Subscribe To
Medicinova stock up on european patent award
Medicinova Inc (NASDAQ:MNOV) stock started Wednesday on the front foot boosted by a patent award in Europe. The European Patent Office has given prote...
August 16, 2023, 10:15 am
Medicinova receives a new patent covering mn-001 for the treatment of scleroderma and systemic sclerosis in europe
LA JOLLA, Calif., Aug. 15, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
August 15, 2023, 11:00 pm
Medicinova receives a notice of allowance for a new patent covering mn-001 for the treatment of advanced nash in canada
LA JOLLA, Calif., April 30, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) a...
April 30, 2023, 11:00 pm
Medicinova receives a notice of allowance for a new patent covering mn-001 and mn-002 for the treatment of scleroderma and systemic sclerosis in canada
LA JOLLA, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
January 11, 2023, 3:00 am
Medicinova announces additional positive results regarding the effects of mn-001 (tipelukast) on serum lipid panel in type 2 diabetes and nafld patients presented at idf 2022 congress, the annual meet
LA JOLLA, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
December 6, 2022, 11:00 pm
Medicinova announces additional positive results regarding the effects of mn-001 (tipelukast) on serum lipid panel in type 2 diabetes and nafld patients presented at idf 2022 congress, the annual meet
LA JOLLA, Calif., Dec. 06, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) an...
December 6, 2022, 11:00 pm